Tudor Investment Corp ET AL boosted its stake in Chemours Company (The) (NYSE:CC) by 11.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,156 shares of the specialty chemicals company’s stock after purchasing an additional 4,883 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Chemours Company (The) were worth $1,750,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Financial Architects Inc increased its stake in Chemours Company (The) by 1,230.3% during the second quarter. Financial Architects Inc now owns 2,940 shares of the specialty chemicals company’s stock worth $111,000 after acquiring an additional 2,719 shares during the last quarter. Acrospire Investment Management LLC lifted its stake in shares of Chemours Company (The) by 3.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock valued at $117,000 after purchasing an additional 100 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Chemours Company (The) by 2,138.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 3,112 shares of the specialty chemicals company’s stock valued at $118,000 after purchasing an additional 2,973 shares in the last quarter. Schroder Investment Management Group acquired a new position in shares of Chemours Company (The) in the 1st quarter valued at about $156,000. Finally, Smithfield Trust Co. lifted its stake in shares of Chemours Company (The) by 521.4% in the 2nd quarter. Smithfield Trust Co. now owns 4,791 shares of the specialty chemicals company’s stock valued at $182,000 after purchasing an additional 4,020 shares in the last quarter. Hedge funds and other institutional investors own 72.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/chemours-company-the-cc-position-raised-by-tudor-investment-corp-et-al/1605416.html.

CC has been the topic of several recent research reports. BidaskClub lowered shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a report on Friday, August 11th. Jefferies Group LLC reiterated a “buy” rating and issued a $48.00 price target on shares of Chemours Company (The) in a report on Friday, June 16th. Citigroup Inc. upgraded Chemours Company (The) from a “neutral” rating to a “buy” rating and increased their price target for the company from $43.00 to $45.00 in a report on Wednesday, July 5th. Zacks Investment Research raised Chemours Company (The) from a “hold” rating to a “strong-buy” rating and set a $51.00 price objective on the stock in a research report on Friday, July 14th. Finally, Argus reissued a “buy” rating and issued a $55.00 price objective (up from $50.00) on shares of Chemours Company (The) in a research report on Thursday, August 10th. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $51.50.

In other news, insider E Bryan Snell sold 10,000 shares of the business’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $46.24, for a total value of $462,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Amy Trojanowski sold 2,500 shares of the business’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $46.03, for a total transaction of $115,075.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,837 shares of company stock worth $1,865,603. Corporate insiders own 1.14% of the company’s stock.

Chemours Company (CC) traded up 0.47% on Tuesday, hitting $53.00. 124,589 shares of the stock were exchanged. The company has a market cap of $9.79 billion, a P/E ratio of 34.69 and a beta of 3.60. Chemours Company has a one year low of $14.41 and a one year high of $53.07. The company’s 50 day moving average price is $50.84 and its 200-day moving average price is $50.84.

Chemours Company (The) (NYSE:CC) last posted its earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.85 by $0.02. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.49 billion. Chemours Company (The) had a return on equity of 122.97% and a net margin of 4.96%. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.27 EPS. Equities research analysts predict that Chemours Company will post $3.51 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 15th. Shareholders of record on Thursday, August 17th were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Tuesday, August 15th. This represents a $0.12 annualized dividend and a yield of 0.23%. Chemours Company (The)’s dividend payout ratio (DPR) is presently 8.11%.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.